Literature DB >> 7217718

Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse.

D M Williams, J Schachter, D J Drutz, C V Sumaya.   

Abstract

Athymic nude mice (nu/nu) were significantly more susceptible to pneumonia due to the agent of mouse pneumonitis (MoPn), Chlamydia trachomatis, than their heterozygous (nu/+) littermates, as judged both by a greater mortality and a decreased ability to rid their lungs of the infection. Nu/nu mice did not produce significant antibody to the MoPn agent, whereas nu/+ mice did. Thymic transplantation rendered nu/nu mice significantly more resistant to the MoPn agent than nu/nu controls. Resistance to the MoPn agent and production of specific antibody to the MoPn agent were dependent on thymus-derived cells.

Entities:  

Mesh:

Year:  1981        PMID: 7217718     DOI: 10.1093/infdis/143.2.238

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6.

Authors:  D M Magee; J G Smith; C A Bleicker; C J Carter; L F Bonewald; J Schachter; D M Williams
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

3.  Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge.

Authors:  J M Vuola; V Puurula; M Anttila; P H Mäkelä; N Rautonen
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Vaccination with major outer membrane protein proteosomes elicits protection in mice against a Chlamydia respiratory challenge.

Authors:  Delia F Tifrea; Sukumar Pal; Deana N Toussi; Paola Massari; Luis M de la Maza
Journal:  Microbes Infect       Date:  2013-08-30       Impact factor: 2.700

5.  Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.

Authors:  D M Williams; L F Bonewald; G D Roodman; G I Byrne; D M Magee; J Schachter
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

6.  A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection.

Authors:  D M Williams; B G Grubbs; T Darville; K Kelly; R G Rank
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis).

Authors:  D M Williams; J Schachter; M H Weiner; B Grubbs
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Role of natural killer cells in infection with the mouse pneumonitis agent (murine Chlamydia trachomatis).

Authors:  D M Williams; J Schachter; B Grubbs
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

9.  Immune response in mice infected in the genital tract with mouse pneumonitis agent (Chlamydia trachomatis biovar).

Authors:  A L Barron; R G Rank; E B Moses
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

10.  A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis.

Authors:  D M Williams; D M Magee; L F Bonewald; J G Smith; C A Bleicker; G I Byrne; J Schachter
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.